Impact BioMedical Inc.
IBO
$0.55
-$0.03-5.64%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 272.89% | -53.47% | -28.23% | 215.89% | 66.89% |
| Depreciation & Amortization | 0.71% | 2.51% | 2.49% | 3.23% | 1.07% |
| Other Operating Expenses | -41.74% | -36.28% | 142.22% | 816.67% | 3,733.33% |
| Total Operating Expenses | 127.33% | 33.14% | -14.29% | 85.30% | 31.00% |
| Operating Income | -126.63% | -32.34% | 15.88% | -84.19% | -31.00% |
| Income Before Tax | -78.72% | 109.80% | -134.78% | -1,523.53% | -28.06% |
| Income Tax Expenses | -- | -7,918.18% | -- | -- | -- |
| Earnings from Continuing Operations | -78.72% | 119.29% | -134.78% | -1,523.53% | -28.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -127.27% | -60.00% | -16.67% | 220.00% | -69.44% |
| Net Income | -80.51% | 119.35% | -134.61% | -1,513.72% | -31.70% |
| EBIT | -126.63% | -32.34% | 15.88% | -84.19% | -31.00% |
| EBITDA | -297.50% | 0.11% | 91.82% | -84.16% | -31.08% |
| EPS Basic | 79.81% | 102.48% | -132.67% | -1,224.30% | -9.15% |
| Normalized Basic EPS | 79.63% | 120.22% | -132.57% | -1,218.28% | -11.05% |
| EPS Diluted | 80.73% | 102.43% | -301.00% | -1,211.11% | -10.00% |
| Normalized Diluted EPS | 79.63% | 120.22% | -303.79% | -1,218.28% | -11.05% |
| Average Basic Shares Outstanding | 793.55% | 679.94% | 5.92% | 21.89% | 20.63% |
| Average Diluted Shares Outstanding | 793.55% | 679.94% | -83.08% | 21.89% | 20.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |